CMS has announced that the Oncology Care Model (OCM) developed by the Center for Medicare and Medicaid Innovation has 196 practices and 17 payers enrolled for participation.
The Oncology Care Model (OCM) developed by the Center for Medicare and Medicaid Innovation (CMMI) has 196 practices and 17 payers enrolled for participation, CMS announced earlier today. The OCM, a 5-year model that begins on July 1, 2016, and runs through June 30, 2021, is focused on providing better, more coordinated care.
The OCM is a value-based model that includes financial and performance accountability for episodes of care for chemotherapy administration in patients with cancer, with the objective of improving care while lowering costs. Shared decision-making with patients is encouraged under the OCM, and physicians are provided an incentive to comprehensively address the complex care needs of patients receiving chemotherapy, while improving outcomes.
Participation of commercial payers is an added incentive for practices to participate in the model. Aligned financial incentives among commercial health plans and CMS will help the model reach a much broader population of patients. Additionally, payers will have the flexibility to design their own payment incentives for providers while aligning with CMMIs goals of care.
With a 6-month episode that begins with chemotherapy, participating practices are expected to:
The 2 part payment system under OCM includes a per-beneficiary Monthly Enhanced Oncology Service payment for the duration of the episode, which is set at $160. There is also the potential for a performance-based payment for episodes of chemotherapy care, an incentive to lower total costs and improve care rendered during a defined episode.
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Traditional Medicare Supplemental Insurance and the Rise of Medicare Advantage
May 7th 2024Rising Medicare Advantage enrollment occurred alongside declines in enrollment in traditional Medicare with employer-sponsored supplemental coverage and traditional Medicare without supplemental coverage.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America
May 6th 2024CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.
Read More
Health Equity and Access Weekly Roundup: May 4, 2024
May 4th 2024This week, the Center on Health Equity and Access highlights a variety of gaps that exist in health care, spanning women's health, the rising rate of metabolic disease, and policy for LGBTQ+ and immigrant populations. The consensus among featured experts points to comprehensive care models.
Read More